Portal Vein Embolisation with Application of Haematopoietic Stem Cells in Patients with Primarily or Non-resectable Colorectal Liver Metastases

Abstract

Insufficient future liver remnant volume (FLRV) is the main cause of low resectability of liver metastases from colorectal cancer (CLMs). One option for enhancing FLVR growth is the use of portal vein embolisation (PVE) with the application of autologous haematopoietic stem cells (HSCs).

Keywords

• Colorectal liver metastases
• future liver remnant volume
• portal vein embolisation
• haematopoietic stem cells